- Trials with a EudraCT protocol (49)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
49 result(s) found for: Muscle Spasm.
Displaying page 1 of 3.
EudraCT Number: 2019-002623-14 | Sponsor Protocol Number: GWSP18023 | Start Date*: 2020-03-17 | ||||||||||||||||
Sponsor Name:GW Pharma Ltd | ||||||||||||||||||
Full Title: A Double-blind, Randomized, Placebo-controlled, Parallel-group Trial of the Efficacy and Safety of Nabiximols Oromucosal Spray as Add-on Therapy in Patients with Spasticity Due to Multiple Sclerosis | ||||||||||||||||||
Medical condition: Symptomatic relief of spasticity in Multiple Sclerosis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Completed) PL (Completed) GB (GB - no longer in EU/EEA) RO (Ongoing) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-004306-58 | Sponsor Protocol Number: GWSP20104 | Start Date*: 2022-01-28 | |||||||||||
Sponsor Name:GW Pharma Limited | |||||||||||||
Full Title: A randomized double-blind placebo-controlled study of nabiximols in patients with spasticity in multiple sclerosis | |||||||||||||
Medical condition: Symptomatic treatment of spasticity in patients with MS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001031-63 | Sponsor Protocol Number: AV650-018 | Start Date*: 2007-09-20 | |||||||||||
Sponsor Name:Avigen Inc | |||||||||||||
Full Title: AV650-018: A two-part (double-blind followed by open-label), placebo-controlled, randomized trial to assess the safety, tolerability, and preliminary efficacy of AV650 (tolperisone HCl) in subjects... | |||||||||||||
Medical condition: Spasticity associated with multiple sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002625-29 | Sponsor Protocol Number: GWSP19066 | Start Date*: 2020-01-14 | ||||||||||||||||
Sponsor Name:GW Pharma Limited | ||||||||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients with Multiple Sclerosis | ||||||||||||||||||
Medical condition: Symptomatic treatment of spasticity in patients with multiple sclerosis (MS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Ongoing) GB (GB - no longer in EU/EEA) CZ (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2020-003271-18 | Sponsor Protocol Number: GWSP20105 | Start Date*: 2021-06-07 | ||||||||||||||||
Sponsor Name:GW Pharma Limited | ||||||||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, 2-way Crossover Trial to Evaluate the Effect of Nabiximols Oromucosal Spray on Clinical Measures of Spasticity in Patients with Multiple Sclerosis | ||||||||||||||||||
Medical condition: Symptomatic treatment of spasticity in patients with multiple sclerosis (MS) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Ongoing) ES (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-000236-16 | Sponsor Protocol Number: IPX056-B06-03 | Start Date*: 2007-05-28 | |||||||||||
Sponsor Name:IMPAX Laboratories, Inc. | |||||||||||||
Full Title: A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects with Establis... | |||||||||||||
Medical condition: Established Spasticity Resulting from Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002315-98 | Sponsor Protocol Number: MedicalcannabisMSSCI2018 | Start Date*: 2018-12-06 | ||||||||||||||||
Sponsor Name:Aarhus Universitetshospital | ||||||||||||||||||
Full Title: The effect of medical cannabis on neuropathic pain and spasticity in patients with Multiple Sclerosis and in patients with spinal cord injury. A multicenter national placebo-controlled trial | ||||||||||||||||||
Medical condition: Central neuropathic pain and spasticity | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-003951-11 | Sponsor Protocol Number: MRZ60201-0410 | Start Date*: 2006-01-25 | |||||||||||
Sponsor Name:Merz Pharmaceuticals GmbH | |||||||||||||
Full Title: Prospective, double-blind, placebo-controlled, randomized, multi-center trial with an open-label extension period to investigate the efficacy and safety of NT 201 in the treatment of post-stroke sp... | |||||||||||||
Medical condition: Post-stroke spasticity of the upper limb | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001034-10 | Sponsor Protocol Number: SativexStroke | Start Date*: 2016-12-07 | |||||||||||
Sponsor Name:IRCCS-A.O.U. SAN MARTINO-IST | |||||||||||||
Full Title: Neurophysiological assessment of the effect of Sativex (THC/CBD oromucosal spray) as add-on to treat spasticity following stroke | |||||||||||||
Medical condition: Spasticity following stroke | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003518-41 | Sponsor Protocol Number: 2018-4765 | Start Date*: 2019-10-03 |
Sponsor Name:Radboudumc | ||
Full Title: Efficacy of Diltiazem to improve coronary microvascular dysfunction: A randomized clinical trial | ||
Medical condition: Coronary Microvascular Dysfunction (CMD). In CMD, ischemia is caused by impaired endothelial and/or non-endothelial coronary vasoreactivity resulting in the coronary microvasculature not dilating p... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-001777-31 | Sponsor Protocol Number: IG2021370 | Start Date*: 2023-05-08 |
Sponsor Name:Hospital de Neurorrehabilitación Institut Guttmann | ||
Full Title: Pilot study on the effect of cannabinoids THC + CBD on resistant spasticity in patients with chronic spinal cord injury. | ||
Medical condition: Pilot study on the effect of THC+CBD cannabinoids on resistant spasticity in patients with chronic spinal cord injury. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-003036-30 | Sponsor Protocol Number: MRZ 60201-0607/1 | Start Date*: 2007-03-08 | |||||||||||
Sponsor Name:Merz Pharmaceuticals GmbH | |||||||||||||
Full Title: Ensaio clínico prospectivo, randomizado, de observador cego, com grupos paralelos e multicêntrico, para avaliar a eficácia e a segurança de duas diluições diferentes de NT 201 em pacientes com espa... | |||||||||||||
Medical condition: Chronic upper limb spasticity caused by diverse etiologies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: PT (Completed) DE (Completed) GB (Completed) AT (Completed) FR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004412-11 | Sponsor Protocol Number: CBX-001 | Start Date*: 2015-01-16 | |||||||||||
Sponsor Name:Canbex Therapeutics Ltd | |||||||||||||
Full Title: A Phase II Proof of Concept (PoC), Double-Blind, Randomised, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VSN16R for the Treatment of Spasticity in Subjects wi... | |||||||||||||
Medical condition: Multiple Sclerosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-004934-26 | Sponsor Protocol Number: N/A | Start Date*: 2008-11-26 | ||||||||||||||||
Sponsor Name:UMCG | ||||||||||||||||||
Full Title: Pharmacokinetics and –dynamics of intrathecal baclofen therapy in patients with spasticity | ||||||||||||||||||
Medical condition: Spasticity of varying origin (i.e. MS, spinal cord injury), which doesn't respond on treatment with oral medication | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000073-29 | Sponsor Protocol Number: MRZ 60201-0528/1 | Start Date*: 2006-07-10 | |||||||||||
Sponsor Name:Merz Pharmaceuticals GmbH | |||||||||||||
Full Title: Prospective, randomised, double-blind, placebo-controlled multicentre pilot trial to investigate the impact of an early use of NT 201 in patients with an acute cerebrovascular event on the developm... | |||||||||||||
Medical condition: Patients with acute cerebrovascular event showing signs of beginning upper limb spasticity | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000985-36 | Sponsor Protocol Number: EMCAM-2011-001 | Start Date*: 2013-02-22 | |||||||||||
Sponsor Name:JOSE MANUEL GARCIA DOMINGUEZ | |||||||||||||
Full Title: Study on the Use of surface electromyography in the detection of objective differencies in patients with spasticity due to multiple sclerosis identified as "responders" and "not responders" under t... | |||||||||||||
Medical condition: Spasticity due to multiple sclerosis identified as "responders" and "not responders" under treatment with Sativex | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004834-42 | Sponsor Protocol Number: 191622-057-02 | Start Date*: 2006-09-11 | |||||||||||
Sponsor Name:Allergan | |||||||||||||
Full Title: A Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group Safety Study of Pulmonary Function in Patients with Reduced Lung Function Treated with BOTOX® (Botulinum Toxin Type A) Purified Neur... | |||||||||||||
Medical condition: Focal upper limb spasticity due to upper motor neuron syndrome including poststroke spasticity. (for the objective of this study patients must also have stable compromised baseline respiratory status) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003771-18 | Sponsor Protocol Number: GWSP08258 | Start Date*: 2013-08-06 | |||||||||||
Sponsor Name:GW Pharma Ltd. | |||||||||||||
Full Title: The efficacy, safety and tolerability of Sativex as an adjunctive treatment to existing anti-spasticity medications in children aged 8 to 18 years with spasticity due to cerebral palsy or traumatic... | |||||||||||||
Medical condition: Spasticity due to cerebral palsy (CP) or traumatic central nervous system injury. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) CZ (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-004725-40 | Sponsor Protocol Number: ECOBT | Start Date*: 2015-11-04 |
Sponsor Name:Consorci Mar Parc de Salut de Barcelona (Parc de Salut MAR) | ||
Full Title: Interfascial effectiveness of ultrasound-guided blocking in transurethral resection of bladder tumor | ||
Medical condition: Bladder cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-005328-14 | Sponsor Protocol Number: SATIVEX-2013 | Start Date*: 2013-04-16 | |||||||||||||||||||||
Sponsor Name:Spinal Cord Injury Centre of Western Denmark | |||||||||||||||||||||||
Full Title: Effect of Sativex on neuropathic pain and spasticity following spinal cord injury | |||||||||||||||||||||||
Medical condition: Neuropathic pain and spasticity following spinal cord injury | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.